14-05-2024
|
|
|
Shilpa Medicare Limited has informed the Exchange regarding 'Clinical Trial Announcement for SML 007 '. |
|
|
|
07-05-2024
|
|
|
Shilpa Medicare Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. |
|
|
|
03-05-2024
|
|
|
Shilpa Medicare Limited has informed the Exchange regarding 'NLCT order on Merger of Shilpa Therapeutics Private Limited, a wholly owned subsidiary with Shilpa Medicare Limited, Holding company'. |
|
|
|
18-04-2024
|
|
|
Shilpa Medicare Limited has informed the Exchange regarding 'Launch of Pemetrexed Injection,'. |
|
|
|
16-04-2024
|
|
|
Shilpa Medicare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 |
|
|
|
16-04-2024
|
|
|
Shilpa Medicare Limited has informed the Exchange regarding ''Europe GMP Approval of Shilpa Medicare Ltd. Unit 4, Jadcherla, Telangana. |
|
|
|
13-04-2024
|
|
|
Shilpa Medicare Limited has informed the Exchange regarding Outcome of Committee Meeting held on April 13, 2024. |
|
|
|
12-04-2024
|
|
|
Shilpa Medicare Limited has informed the Exchange regarding Outcome of Committee Meeting held on April 12, 2024. |
|
|
|
09-04-2024
|
|
|
Shilpa Medicare Limited has informed the Exchange regarding Committee Meeting to be held on April 12, 2024. |
|
|
|
09-04-2024
|
|
|
Shilpa Medicare Limited has informed the Exchange about qualified Institutional Placement |
|
|
|
|